NCBI Taxonomy: 585813

Iris foetidissima (ncbi_taxid: 585813)

found 34 associated metabolites at species taxonomy rank level.

Ancestor: Iris

Child Taxonomies: none taxonomy data.

Irigenin

4H-1-Benzopyran-4-one,5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-

C18H16O8 (360.0845136)


Irigenin, also known as 5,7,3-trihydroxy-6,4,5-trimethoxyisoflavone, is a member of the class of compounds known as 3-hydroxy,4-methoxyisoflavonoids. 3-hydroxy,4-methoxyisoflavonoids are isoflavonoids carrying a methoxy group attached to the C4 atom, as well as a hydroxyl group at the C3-position of the isoflavonoid backbone. Thus, irigenin is considered to be a flavonoid lipid molecule. Irigenin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Irigenin can be synthesized from isoflavone. Irigenin can also be synthesized into iridin. Irigenin can be found in lima bean, which makes irigenin a potential biomarker for the consumption of this food product. Irigenin is an O-methylated isoflavone, a type of flavonoid. It can be isolated from the rhizomes of the leopard lily (Belamcanda chinensis), and Iris kemaonensis . Irigenin is a hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3 and methoxy groups at positions 6, 4 and 5 respectively. It has a role as a plant metabolite. It is a hydroxyisoflavone and a member of 4-methoxyisoflavones. It is functionally related to an isoflavone. Irigenin is a natural product found in Iris milesii, Iris tectorum, and other organisms with data available. Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells[1]. Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells[1].

   

Iridin

5-hydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

C24H26O13 (522.1373346)


Iridin is a glycosyloxyisoflavone that is irigenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It has a role as a plant metabolite. It is a hydroxyisoflavone, a monosaccharide derivative, a member of 4-methoxyisoflavones and a 7-hydroxyisoflavones 7-O-beta-D-glucoside. It is functionally related to an irigenin. Iridin is a natural product found in Iris milesii, Iris tectorum, and other organisms with data available. See also: Iris versicolor root (part of). A glycosyloxyisoflavone that is irigenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. Iridin is an isoflavone isolated from Iris milesii[1]. Iridin is an isoflavone isolated from Iris milesii[1].

   

Irigenin

4H-1-Benzopyran-4-one,5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-

C18H16O8 (360.0845136)


Irigenin is a hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3 and methoxy groups at positions 6, 4 and 5 respectively. It has a role as a plant metabolite. It is a hydroxyisoflavone and a member of 4-methoxyisoflavones. It is functionally related to an isoflavone. Irigenin is a natural product found in Iris milesii, Iris tectorum, and other organisms with data available. A hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3 and methoxy groups at positions 6, 4 and 5 respectively. Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells[1]. Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells[1].

   

2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal

2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1r,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hex-3-en-1-yl]cyclohexylidene]propanal

C31H52O3 (472.3916242)


   

2-hydroxy-5-methoxy-3-octadecylcyclohexa-2,5-diene-1,4-dione

2-hydroxy-5-methoxy-3-octadecylcyclohexa-2,5-diene-1,4-dione

C25H42O4 (406.30829320000004)


   

2-[(1r,2s,5s,6r,7z,10s)-1,10-dihydroxy-2-[(2e,4e,6e)-1-hydroxy-6,10-dimethylundeca-2,4,6,9-tetraen-2-yl]-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

2-[(1r,2s,5s,6r,7z,10s)-1,10-dihydroxy-2-[(2e,4e,6e)-1-hydroxy-6,10-dimethylundeca-2,4,6,9-tetraen-2-yl]-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

C30H46O5 (486.3345066)


   

2-[(1r,2s,5s,6r,7z,10s)-2-[(3e,5e)-6,10-dimethylundeca-1,3,5,9-tetraen-2-yl]-1,10-dihydroxy-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

2-[(1r,2s,5s,6r,7z,10s)-2-[(3e,5e)-6,10-dimethylundeca-1,3,5,9-tetraen-2-yl]-1,10-dihydroxy-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

C30H46O4 (470.3395916)


   

2-[1,10-dihydroxy-2-(1-hydroxy-6,10-dimethylundeca-2,4,6,9-tetraen-2-yl)-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

2-[1,10-dihydroxy-2-(1-hydroxy-6,10-dimethylundeca-2,4,6,9-tetraen-2-yl)-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

C30H46O5 (486.3345066)


   

2-[(1z,2s,3r,4r)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1s,5r)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]hex-3-en-1-yl]cyclohexylidene]propanal

2-[(1z,2s,3r,4r)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e)-4-methyl-6-[(1s,5r)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]hex-3-en-1-yl]cyclohexylidene]propanal

C31H52O3 (472.3916242)


   

2-[(1z,2r,3s,4s)-4-hydroxy-3-[(3e,5r,7e)-5-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-2-(3-hydroxypropyl)-3,4-dimethylcyclohexylidene]propanal

2-[(1z,2r,3s,4s)-4-hydroxy-3-[(3e,5r,7e)-5-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-2-(3-hydroxypropyl)-3,4-dimethylcyclohexylidene]propanal

C30H50O4 (474.37089000000003)


   

2-[4-hydroxy-3-(5-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2-(3-hydroxypropyl)-3,4-dimethylcyclohexylidene]propanal

2-[4-hydroxy-3-(5-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2-(3-hydroxypropyl)-3,4-dimethylcyclohexylidene]propanal

C30H50O4 (474.37089000000003)


   

2-[2-(6,10-dimethylundeca-1,3,5,9-tetraen-2-yl)-1,10-dihydroxy-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

2-[2-(6,10-dimethylundeca-1,3,5,9-tetraen-2-yl)-1,10-dihydroxy-6-(3-hydroxypropyl)-10-methylspiro[4.5]decan-7-ylidene]propanal

C30H46O4 (470.3395916)


   

2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]cyclohexylidene]propanal

2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]cyclohexylidene]propanal

C30H50O3 (458.37597500000004)